Avastin dramatically improves response, survival in deadly recurrrent glioblastomas
Wednesday, September 2, 2009 - 15:42
in Health & Medicine
The targeted therapy Avastin, alone and in combination with the chemotherapy drug CPT-11, significantly increased response rates, progression-free survival times and survival rates in patients with a deadly form of brain cancer that had recurred.